BioCentury
ARTICLE | Company News

HemaSure, German Red Cross deal

March 25, 1996 8:00 AM UTC

HMSR licensed from the German Red Cross rights to methylene blue technology, which inactivates lipid-enveloped viruses in transfusion plasma. The German Red Cross also received an option to enter int...